You are probably correct in indicating that the dilution of GPN's shareholding in YRR could be a contributing factor in their ailing sp.
However, if YRR's assets apart from the Gabanintha vanadium are proven to be equal or better than the value that they have paid for them, and the sp consequently returns to former high levels, GPN still owns the same number of units (60 million) in YRR - so if Gaba is only worth what was previously factored in, then the dilution in YRR may be irrelevant to GPN.
There are 2 big "ifs" here: 1. AUL & Cabe being worth more than what was paid. 2. Gaba being only worth what was factored in.
The directors apparently, if not obviously, think that # 1 is true.
I support your call for full details of drill results, red-frog.
GPN Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held